Previous 10 | Next 10 |
First Quarter Total Net Revenue Increased 30% to $34.6 Million Full-Year 2021 Revenue Guidance Raised to $165-$168 Million Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., May 05, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in...
Vericel (NASDAQ:VCEL) is scheduled to announce Q1 earnings results on Wednesday, May 5th, before market open.The consensus EPS Estimate is -$0.04 (+60.0% Y/Y) and the consensus Revenue Estimate is $32.04M (+20.1% Y/Y).Over the last 2 years, VCEL has beaten EPS estimates 75% of the time and ha...
CAMBRIDGE, Mass., April 21, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the following webcast and conference call to discuss its first-quarter 2021 financial results and busi...
Shares of Vericel Corporation (NASDAQ:VCEL) traded today at $63.54, eclipsing its 52-week high. This new high was reached on below average trading volume as 264,000 shares traded hands, while the average 30-day volume is approximately 1.2 million shares. Vericel Corporation share prices ...
CAMBRIDGE, Mass., April 09, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will present the latest company overview at the 20 th Annu...
Are These The Top Biotech Stocks to Buy Right Now? Biotech stocks have been a hot topic among investors these days. This comes as the U.S. undergoes mass vaccination against the coronavirus. Investors are always on the lookout for top biotech stocks that could be the next big th...
Gainers: Neos Therapeutics (NEOS) +17%,Aytu BioScience (AYTU) +14%, Vericel (VCEL) +14%, Brickell Biotech (BBI) +14%, Infinity Pharmaceuticals (INFI) +13%.Losers: Translate Bio (TBIO) -32%, ContraFect (CFRX) -13%, Lipocine (LPCN...
Vericel Set to Join S&P SmallCap 600 Vericel Set to Join S&P SmallCap 600 PR Newswire NEW YORK , March 17, 2021 /PRNewswire/ -- Vericel Corp. (NASD:VCEL) will replace QEP Resources Inc. (NYSE:QEP) in the S&P SmallCap 600 effective prior to th...
Vericel (VCEL) has jumped 10.2% after hours on news that it will join the S&P SmallCap 600 index. It's moving in there to take the place of QEP Resources (QEP), which has just been acquired by S&P 500 constituent Diamondback Energy. The move is effective prior to the open of trading o...
The following slide deck was published by Vericel Corporation in conjunction with this event. For further details see: Vericel (VCEL) Presents At H.C. Wainwright Global Life Sciences 2021 Virtual Conference - Slideshow
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the appointment of Karen Mahoney as Chief Human Resources Officer following the retirement of Heidi Hassen, w...
CAMBRIDGE, Mass., July 18, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that it will report its second-quarter 2024 financial results on Thursday, August 1, 2024. Vericel’s m...
2024-07-08 00:00:04 ET Ryan Zimmerman from BTIG issued a price target of $56.00 for VCEL on 2024-07-05 10:09:00. The adjusted price target was set to $56.00. At the time of the announcement, VCEL was trading at $46.68. The overall price target consensus is at $48.00 with...